scispace - formally typeset
P

Patrick R. Hof

Researcher at Icahn School of Medicine at Mount Sinai

Publications -  834
Citations -  73115

Patrick R. Hof is an academic researcher from Icahn School of Medicine at Mount Sinai. The author has contributed to research in topics: Neocortex & Alzheimer's disease. The author has an hindex of 130, co-authored 796 publications receiving 64987 citations. Previous affiliations of Patrick R. Hof include Albert Einstein College of Medicine & National Institutes of Health.

Papers
More filters
Journal ArticleDOI

Cortical microinfarcts and demyelination affect cognition in cases at high risk for dementia.

TL;DR: Cortical microinfarcts and, to a lesser degree, periventricular demyelination contribute to the cognitive decline in individuals at high risk for dementia.
Book ChapterDOI

Life and death of neurons in the aging cerebral cortex.

TL;DR: Estrogen levels affect spine density on pyramidal neurons in the prefrontal cortex; these neurons may provide many of the same circuits implicated in AAMI and suggest that the synaptic alterations prevalent in normal aging may be responsive to therapy.
Journal ArticleDOI

Mice Lacking Dopamine D2 and D3 Receptors Exhibit Differential Activation of Prefrontal Cortical Neurons during Tasks Requiring Attention

TL;DR: D dopamine differentially modulates prefrontal cortical activity during tasks requiring attention depending upon the type of D2-like receptor that is activated, indicating that response accuracy in the cognitive test correlates with the magnitude of prefrontal cortical activation regardless of which test phases revealed different performances.
Journal ArticleDOI

Differential vulnerability of oculomotor, facial, and hypoglossal nuclei in G86R superoxide dismutase transgenic mice.

TL;DR: The relatively moderate and late involvement of the hypoglossal nucleus indicates that, although the general patterns of neuronal pathology match closely those seen in ALS patients, some differences exist in this transgenic model compared with the progression of the disease in humans.